Narrator: GlaxoSmithKline defined a bold vision,
achieving new heights of operational excellence.
To realize that vision,
the pharmaceutical giant set out to leverage data
to make bold transformational moves and integrate data
and analytics into all company operations.
GSK plan to unlock more than 1 billion pounds of new value
over three years by tapping into its existing data
using advances in computing power and AI.
In partnership with BCG, GSK followed a powerful mantra,
"Think Big, Start Small, Scale Fast".
Leaders identified data and analytics opportunities
that they believed could each unlock
over 100 million pounds worth of P&L or cash value.
To execute these key initiatives,
cross-functional squads of business,
technology, and data science expertise were set up.
Squads united multiple disciplines to test
and improve algorithms and products in rapid sprints
and to share learnings across the organization.
Digitizing the supply chain is just one example
of how the squads accelerated value delivery
and impact by developing data-based tools
such as digital value stream mapping
and a safety stock optimizer to make sure GSK
would always have enough inventory of medicines
to deliver quickly and reliably to patients.
And the numbers speak volumes, optimizing the first SKU
for a vaccine brand took 14 days,
the remaining SKUs, seven days,
and all the SKUs for the next brand took just two days.
Across all initiatives,
the first 15 months saw delivery of 400 million
of the identified 1 billion pounds of potential new value.
These squads also served as the starting point
for building GSK's own internal capabilities,
transforming siloed expertise to over 200 data
and analytics experts working across operations
around the globe, helping position GSK to tackle
the many challenges arising from the COVID-19 pandemic.
And the journey has just begun.
GSK plans to continue supercharging its data
and analytics capabilities to overcome new hurdles
and ensure all decisions are data-driven in the future.
This approach will support GSK's mission
to help people do more, feel better, live longer.
This is success by design.